Last $87.15 USD
Change Today -1.19 / -1.35%
Volume 5.1M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
NASDAQ GM
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Perry A. Karsen

Chief Operations Officer, Executive Vice President and Chief Executive Officer of Celgene Cellular Therapeutics, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 47 board members in 5 different organizations across 10 different industries.

See Board Relationships
59$7,051,343
As of Fiscal Year 2013

Background*

Mr. Perry A. Karsen serves as the President of Stalar 4, Inc. and Stalar 3 Inc. Mr. Karsen has been the Chief Operations Officer at Celgene Corporation since July 2010 and has been its Executive Vice President since February 15, 2012. He serves as an Executive Officer of Healthcare IT, Inc. (also known as Ardais Corporation). He serves as Chief Executive Officer of Celgene Cellular Therapeutics, a wholly owned subsidiary of Celgene Corporation. Mr. Karsen served as the ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

Former Director
Former Director
Former Director
President and Director
President and Director
2011-Present
Director
2013-Present
Director
2014-Present
Director

Education*

Master's Degree
Duke University
BS
University of Illinois-Urbana-Champaign
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$645,833
Total Annual Compensation$645,833

Stock Options*

Restricted Stock Awards$1,008,796
All Other Compensation$31,129
Exercised Options93,008
Exercised Options Value$8,312,929
Exercisable Options32,922
Unexercisable Options129,512
Total Value of Options$8,312,929
Total Number of Options255,442

Total Compensation*

Total Annual Cash Compensation$3,841,968
Total Short Term Compensation$645,833
Other Long Term Compensation$1,039,925
Total Calculated Compensation$7,051,343
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $87.15 USD -1.19

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.